New research into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are demonstrating encouraging effects in treating weight gain and related second-type disease. Animal information suggest a novel mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/